The problem
Doctors can't keep up with medical literature and need trustworthy answers in seconds during patient care
What they do
AI medical search that gives clinicians cited answers from peer-reviewed literature at the point of care
Traction ~$300M ARR (reported Jul 2026), doubled in 7 months; used by 40%+ of US physicians
Hiring trend
- Open roles
- 8
- Ops roles
- 1
- Headcount
- ~140
~140 staff on LinkedIn (+180% YoY, est.); lean team, 9 open roles mostly Miami
Hiring in
- Miami
- San Francisco
- Remote
Glassdoor
2.5 ★ 2 reviews ↗Funding
- Last round
- $250M
- Stage
- Late stage (post-Series D)
- Date
- Sep 2026
Led by Andreessen Horowitz, Byers Capital
- Hiring+18 open roles on the live job board (3–9 roles = +1)
- Funding recency+2Late stage (post-Series D) · $250M, Sep 2026 (1 month ago): 6 months or less = +1.5, $100M+ round +0.5
- Traction+1.5Strong growth: ~$300M ARR (reported Jul 2026), doubled in 7 months; used by 40%+ of US physicians
- Red flags−11 significant flag in the last 24 months, −1 eachOngoing federal lawsuit with Doximity/Pathway: Jan 2026 ruling let Doximity's counterclaims (alleged misinformation and harassment campaign) proceed alongside OpenEvidence's hacking claims; no settlement as of Aug 2026.Bloomberg Law: OpenEvidence, Doximity advance dispute over AI platform access (Jan 2026) ↗ · CourtListener: joint status report, no settlement reached (Aug 2026) ↗
- Total3.51 + 2 + 1.5 − 1 = 3.5 → Tempo (3.5–4.24)
Distance (Marathon) is a separate read on how long the lead can last. It doesn't change the score.
Distance
Marathon · edge: learns from use
Clear category leader in clinician AI search (used by 40%+ of US physicians, embedded in Epic at Mount Sinai, Sutter, Northwestern) with exclusive journal content deals and ~$300M run-rate; watch the labs and Doximity/UpToDate shipping rival tools to the same doctors.
Sources: CNBC: OpenEvidence used by 40% of US physicians, topped $100M revenue (Jan 2026) ↗ · Becker's: OpenEvidence raises $250M at $15B (Sep 2026) ↗ · Forbes: rivals UpToDate and Doximity entering the market (Oct 2026) ↗
Watch-outs
Ongoing federal lawsuit with Doximity/Pathway: Jan 2026 ruling let Doximity's counterclaims (alleged misinformation and harassment campaign) proceed alongside OpenEvidence's hacking claims; no settlement as of Aug 2026.
Sources: Bloomberg Law: OpenEvidence, Doximity advance dispute over AI platform access (Jan 2026) ↗ · CourtListener: joint status report, no settlement reached (Aug 2026) ↗
Open ops roles · 1
Last checked Oct 25, 2026